tiprankstipranks
Trending News
More News >
Theravance Biopharma (TBPH)
NASDAQ:TBPH
US Market

Theravance Biopharma (TBPH) Income Statement

Compare
344 Followers

Theravance Biopharma Income Statement

Last quarter (Q3 2025), Theravance Biopharma's total revenue was $19.99M, an increase of 18.51% from the same quarter last year. In Q3, Theravance Biopharma's net income was $3.62M. See Theravance Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 64.38M$ 57.42M$ 51.35M$ 55.31M$ 71.86M
Gross Profit
$ 64.38M$ 16.80M$ -12.05M$ -138.35M$ 71.86M
Operating Expenses
$ 111.33M$ 72.84M$ 79.91M$ 119.44M$ 369.48M
Depreciation and Amortization
$ 3.62M$ 2.00M$ 3.04M$ 4.81M$ 6.97M
EBITDA
$ -38.45M$ -51.65M$ -76.08M$ -232.83M$ -287.82M
Operating Income
$ -46.95M$ -56.03M$ -91.96M$ -257.78M$ -297.63M
Other Income/Expenses
$ 2.33M$ 6.77M$ -858.00K$ -7.44M$ -5.72M
Pretax Income
$ -44.61M$ -49.27M$ -92.81M$ -265.22M$ -303.34M
Net Income
$ -56.42M$ -55.19M$ 872.13M$ -199.43M$ -278.02M
Per Share Metrics
Basic EPS
$ -1.15$ -1.00$ -1.26$ -2.87$ -4.46
Diluted EPS
$ -1.15$ -1.00$ -1.26$ -2.87$ -4.46
Weighted Average Shares Outstanding
48.85M 55.30M 73.59M 69.46M 62.34M
Weighted Average Shares Outstanding (Diluted)
48.85M 55.30M 73.59M 69.46M 62.34M
Currency in USD

Theravance Biopharma Earnings and Revenue History